Open AccessLorlatinib and Bevacizumab Activity inALK-Rearranged Lung Cancers After Lorlatinib Progression
Author(s) -
Noura J. Choudhury,
Robert J. Young,
Matthew Sellitti,
Alexandra Miller,
Alexander Drilon
Publication year - 2020
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.20.00271
Subject(s) - bevacizumab , medicine , cancer research , lung , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom